]>
IRCT20111121008146N35 IRCT 2021-05-23 Shahid Beheshti University of Medical Sciences Clinical trial to evaluate the effect of photobiomodulation on cognitive and psychological tests in patients with Alzheimer's disease Clinical trial to evaluate the effect of photobiomodulation on cognitive and psychological tests in patients with Alzheimer's disease 2021-04-30 anticipated 12 Complete https://irct.ir/trial/55835 interventional Randomization: Randomized, Blinding: Single blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: All patients are divided into case and control groups according to the table of random numbers with a ratio of 1: 1. The assigned group of individuals is placed one after the other in dark envelopes, Blinding description: The 12 patients with Alzheimer's disease will be divided into two groups of six. In one group, placebo treatment will be performed by keeping the cap off, and in the second group, photobiomodulation treatment will be performed. Follow-up of the effectiveness of this method will be done 6 and 12 weeks after the start of the study using tests of memory, cognition and function (MOCA, DADS) and psychological tests (Hamilton Anxiety and Depression). N/A Alzheimer. Intervention 1: Intervention group: In addition to the usual treatment, they also use LEDs at home. Intervention 2: Control group: This group receives only the usual treatments. Yes - There is a plan to make this available What will be shared: All data is potentially shareable after unidentified individuals When: Access period starts 6 months after the results are published To whom: Researchers and craftsmen Conditions: Email the corresponding author and earn permission Where to obtain: Email the corresponding author How to obtain: Email the corresponding author, the authors' meeting, send the data at your discretion Comments:
public Maryam Barati
Laser Application in Medical Sciences Research Center, Shohadaye-Tajrish Educational Hospital, Tajrish Sq, Tehran, Iran
Tehran Iran (Islamic Republic of) 1989934370 +98 21 2271 8021 laser.cntr@yahoo.com Shahid Beheshti University of Medical Sciences scientific NeginKimia
Laser Application in Medical Sciences Research Center, Shohadaye-Tajrish Educational Hospital, Tajrish Sq, Tehran, Iran
Tehran Iran (Islamic Republic of) 1989934370 +98 21 2271 8021 negin.kimia20166@gmail.com Shahid Beheshti University of Medical Sciences Iran (Islamic Republic of) Diagnosis of Alzheimer's disease by a neurologist no limit no limit Both f00 Alzheimer disease is a primary degenerative cerebral disease of unknown etiology with characteristic neuropathological and neurochemical features. The disorder is usually insidious in onset and develops slowly but steadily over a period of several years. Treatment - Other N/A Intervention group: In addition to the usual treatment, they also use LEDs at home Control group: This group receives only the usual treatments DADS Test. Timepoint: At the beginning and after the end of the laser course. Method of measurement: questionnaire. MOCA Test. Timepoint: At the beginning and after the end of the laser course. Method of measurement: questionnaire. Hamilton Test. Timepoint: At the beginning and after the end of the laser course. Method of measurement: questionnaire. Shahid Beheshti University of Medical Sciences Approved 2020-12-20 Ethics committee of Shahid Beheshti University of Medical Sciences Laser Application in Medical Sciences Research Center, Shohadaye-Tajrish Educational Hospital, Tajrish Sq, Tehran, Iran. Tehran Tehran Iran (Islamic Republic of)